Literature DB >> 16137181

Application of multiplex ARMS and SSCP/HD analysis in molecular diagnosis of cystic fibrosis in Indian patients.

Tester F Ashavaid1, Altaf A Kondkar, Alpa J Dherai, Rani Raghavan, Soonu V Udani, Zarir F Udwadia, Devendra Desai.   

Abstract

BACKGROUND: Cystic fibrosis (CF) is an autosomal recessive disorder caused by mutations in the CFTR gene. The most severe, DeltaF508, mutation accounts for nearly 70% of CF cases worldwide. Besides DeltaF508, there are other point mutations, namely G542X, G551D, R553X, N1303K, and 621+1(G-->T), which are common among Caucasians. Additionally, a polyT polymorphism in intron 8 is also involved in the pathogenesis of CF. However, neither the prevalence nor the types of mutations causing CF in India are known. In this study, we aimed at estimating the frequency of the above common mutations and polymorphism in clinically suspected CF cases. We also carried out partial analysis of the CFTR gene, limited to exons 10 and 11, to identify other variations in these exons.
METHODS: The multiplex amplification refractory mutation system (ARMS) test was applied for rapid simultaneous analysis of six most common CF mutations, in 100 normal and 39 elevated sweat chloride cases. The scanning of exons 10 and 11 was carried out by single-stranded conformation polymorphism/heteroduplex (SSCP/HD) analysis, followed by DNA sequencing in 50 normal and 37 elevated sweat chloride cases. A single ARMS-polymerase chain reaction assay was used to distinguish the 5T, 7T, and 9T alleles in 100 normal and 33 elevated sweat chloride cases.
RESULTS: The multiplex ARMS analysis identified the DeltaF508 mutation at an allele frequency of 24% in Indian CF cases. However, the other predominant CF mutations were found to be absent. The 7T polyT variant was observed to be the most common allele, followed by the 9T, and 5T, which was the lowest. The DeltaF508 mutation was observed in all instances with the 9T variant. The SSCP/HD and DNA sequencing additionally revealed a known polymorphism (M470V, exon 10) and a known mutation [1525-1(G-->A), intron 9]. The 1525-1(G-->A) mutation, observed in a single 4-year-old male, is predicted to code for a class II defective CFTR protein.
CONCLUSION: The findings of this study suggest a difference in relative frequencies and spectrum of CFTR mutations in Indian CF cases. A larger screening study of the entire CFTR gene in clinically well defined CF cases is required to delineate common mutations in the CFTR gene and enable molecular diagnosis of CF in India.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16137181     DOI: 10.1007/BF03260073

Source DB:  PubMed          Journal:  Mol Diagn        ISSN: 1084-8592


  19 in total

Review 1.  Cystic fibrosis: Indian experience.

Authors:  A S Ahuja; S K Kabra
Journal:  Indian Pediatr       Date:  2002-09       Impact factor: 1.411

2.  Negative sweat tests and cystic fibrosis.

Authors:  J K Sarsfield; J M Davies
Journal:  Arch Dis Child       Date:  1975-06       Impact factor: 3.791

3.  CFTR haplotype backgrounds on normal and mutant CFTR genes.

Authors:  H Cuppens; H Teng; P Raeymaekers; C De Boeck; J J Cassiman
Journal:  Hum Mol Genet       Date:  1994-04       Impact factor: 6.150

4.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

5.  Two buffer PAGE system-based SSCP/HD analysis: a general protocol for rapid and sensitive mutation screening in cystic fibrosis and any other human genetic disease.

Authors:  S Liechti-Gallati; V Schneider; D Neeser; R Kraemer
Journal:  Eur J Hum Genet       Date:  1999-07       Impact factor: 4.246

6.  Delta F 508 molecular mutation in Indian children with cystic fibrosis.

Authors:  M Kabra; M Ghosh; S K Kabra; A Khanna; I C Verma
Journal:  Indian J Med Res       Date:  1996-12       Impact factor: 2.375

7.  Cystic fibrosis in North Indian children.

Authors:  Meenu Singh; Rajendra Prasad; Lata Kumar
Journal:  Indian J Pediatr       Date:  2002-07       Impact factor: 1.967

8.  Development, multiplexing, and application of ARMS tests for common mutations in the CFTR gene.

Authors:  R M Ferrie; M J Schwarz; N H Robertson; S Vaudin; M Super; G Malone; S Little
Journal:  Am J Hum Genet       Date:  1992-08       Impact factor: 11.025

9.  Frequent occurrence of the CFTR intron 8 (TG)n 5T allele in men with congenital bilateral absence of the vas deferens.

Authors:  B Costes; E Girodon; N Ghanem; E Flori; A Jardin; J C Soufir; M Goossens
Journal:  Eur J Hum Genet       Date:  1995       Impact factor: 4.246

Review 10.  Clinical implications of cystic fibrosis transmembrane conductance regulator mutations.

Authors:  J E Mickle; G R Cutting
Journal:  Clin Chest Med       Date:  1998-09       Impact factor: 2.878

View more
  2 in total

Review 1.  Association of CFTR gene mutation with bronchial asthma.

Authors:  Nutan Maurya; Shally Awasthi; Pratibha Dixit
Journal:  Indian J Med Res       Date:  2012-04       Impact factor: 2.375

Review 2.  A Comprehensive Updated Review on Magnetic Nanoparticles in Diagnostics.

Authors:  Pedro Farinha; João M P Coelho; Catarina Pinto Reis; Maria Manuela Gaspar
Journal:  Nanomaterials (Basel)       Date:  2021-12-17       Impact factor: 5.076

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.